TITLE

ADEC RECOMMENDS METVIX MARKETING AUTHORIZATION EXTENSION

PUB. DATE
August 2003
SOURCE
Worldwide Biotech;Aug2003, Vol. 15 Issue 8, p4
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the recommendation of Australian Drug Evaluation Committee to extend the marketing authorization for PhotoCure's Metvix to include the treatment of basal cell carcinoma.
ACCESSION #
10400325

 

Related Articles

  • NEW SKIN SAVER.  // Time International (South Pacific Edition);8/2/2004, Issue 30, p135 

    The article reports that 3M Pharmaceuticals has been allowed by the U.S. government to market Aldara as a therapy for a common type of basal-cell carcinoma (BCC). It has been reported that the drug is not for the treatment of superficial BCC tumors larger in diameter than 2 cm, in those cases,...

  • Basal cell carcinoma vs sebaceous hyperplasia. Jordan, Andy // Pulse;3/16/2011, Vol. 71 Issue 10, p23 

    The article presents a distinction between two similar skin conditions, the basal cell carcinoma (BBC) and sebaceous hyperplasia.

  • Basal cell carcinoma. Kuflik, Avery S.; Janniger, Camila K. // American Family Physician;11/15/1993, Vol. 48 Issue 7, p1273 

    Discusses basal cell carcinoma (BCC). Risk of BCC to fair-skinned persons often exposed to the sun; Clinical types of BCC; Recurrence and metastasis; Treatment.

  • Basal cell carcinoma: When to treat it yourself, and when to refer. Parisier, David M.; Phillips, Pamela K. // Geriatrics;Mar94, Vol. 49 Issue 3, p39 

    Focuses on basal cell carcinoma (BCC), the most common type of skin cancer. Benefits of early detection and recognition; Description of the various clinical presentations; Occurrence of distant metastasis; Need for biopsy in clinical diagnosis.

  • Basal cell carcinoma in a teenage boy. Koch, Susan E.; Miller, Stanley J. // Clinical Pediatrics;Feb1997, Vol. 36 Issue 2, p113 

    Presents the case of a teenage boy with basal cell carcinoma. Patient report; Laboratory report and results of physical examination; Medical intervention and treatment options.

  • Hereditary factors in basal cell carcinoma of the skin: a population-based cohort study in twins—reply. Milan, T.; Kaprio, J.; Verkasalo, P.K.; Jansen, C.T.; Teppo, L.; Koskenvuo, M. // British Journal of Cancer;1/1/2000, Vol. 82 Issue 1, p248 

    Replies to comments made on the article 'Hereditary Factors in Basal Cell Carcinoma of the Skin: A Population-Based Cohort Study in Twins,' published in the journal 'British Journal of Cancer.' Justification related to the conclusion made by the authors related to the study; Basis for...

  • Hereditary factors in basal cell carcinoma of the skin: a population-based cohort study in twins. Bataille, V.; Snieder, H.; MacGregor, A.; Spector, T. // British Journal of Cancer;1/1/2000, Vol. 82 Issue 1, p247 

    Comments on the article 'Hereditary Factors in Basal Cell Carcinoma of the Skin: A Population-Based Cohort Study of Twins,' published in the journal 'British Journal of Cancer.' Issues related to the finding of the study of basal call carcinoma in twins; Several points need to be addressed in...

  • Patients don't seek Tx after screening.  // Dermatology Times;Apr95, Vol. 16 Issue 4, p65 

    Reports that 40% of people examined at screening clinics and suspected to have basal cell carcinomas did not bother to consult a physician afterwards for diagnosis and treatment, according to a survey. Recommendation of the Skin Cancer Foundation.

  • ERRATUM.  // Acta Dermato-Venereologica;2009, Vol. 89 Issue 6, p667 

    A correction to the article "Histology-based Treatment of Basal Cell Carcinoma" that was published in the 2009 issue is presented.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics